JP2021530470A5 - - Google Patents
Info
- Publication number
- JP2021530470A5 JP2021530470A5 JP2021500105A JP2021500105A JP2021530470A5 JP 2021530470 A5 JP2021530470 A5 JP 2021530470A5 JP 2021500105 A JP2021500105 A JP 2021500105A JP 2021500105 A JP2021500105 A JP 2021500105A JP 2021530470 A5 JP2021530470 A5 JP 2021530470A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- compound
- cathepsin
- unsubstituted
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018093886 | 2018-06-30 | ||
| CNPCT/CN2018/093886 | 2018-06-30 | ||
| PCT/CN2019/092488 WO2020001392A1 (en) | 2018-06-30 | 2019-06-24 | Cathepsin c inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021530470A JP2021530470A (ja) | 2021-11-11 |
| JP2021530470A5 true JP2021530470A5 (enExample) | 2022-07-01 |
Family
ID=68986057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500105A Pending JP2021530470A (ja) | 2018-06-30 | 2019-06-24 | カテプシンｃ阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210114983A1 (enExample) |
| EP (1) | EP3814324A4 (enExample) |
| JP (1) | JP2021530470A (enExample) |
| CN (1) | CN112601742A (enExample) |
| WO (1) | WO2020001392A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3846793B1 (en) | 2018-09-07 | 2024-01-24 | PIC Therapeutics, Inc. | Eif4e inhibitors and uses thereof |
| AR121506A1 (es) | 2020-03-03 | 2022-06-08 | Pic Therapeutics Inc | Inhibidores del eif4e y sus usos |
| CN112920124B (zh) * | 2021-01-29 | 2024-03-01 | 安徽医科大学 | 一种嘧啶-2,4-二胺类化合物及其制备方法与应用 |
| US12157732B2 (en) | 2021-08-25 | 2024-12-03 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| IL310924A (en) | 2021-08-25 | 2024-04-01 | Pic Therapeutics Inc | Eif4e inhibitors and uses thereof |
| WO2023243601A1 (ja) | 2022-06-13 | 2023-12-21 | モジュラス株式会社 | アザシクロアルキルカルボニル環状アミン化合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101705158B1 (ko) * | 2009-05-05 | 2017-02-09 | 다나-파버 캔서 인스티튜트 인크. | Ｅｇｆｒ 억제제 및 질환 치료방법 |
| WO2012112733A1 (en) * | 2011-02-16 | 2012-08-23 | Glaxosmithkline Llc | Cathepsin c inhibitors |
| CN103664878A (zh) * | 2012-09-12 | 2014-03-26 | 山东亨利医药科技有限责任公司 | 杂芳环及其衍生物类酪氨酸激酶抑制剂 |
| AU2014287209B2 (en) * | 2013-07-09 | 2019-01-24 | Dana-Farber Cancer Institute, Inc. | Kinase inhibitors for the treatment of disease |
| US10329270B2 (en) * | 2013-10-21 | 2019-06-25 | Merck Patent Gmbh | Heteroaryl compounds as BTK inhibitors and uses thereof |
| CN106536503B (zh) * | 2014-04-18 | 2019-09-06 | 北京澳合药物研究院有限公司 | 一种酪氨酸激酶抑制剂及其用途 |
| ES2912276T3 (es) * | 2015-04-07 | 2022-05-25 | Ela Pharma Ltd | Composiciones para tratar y/o prevenir necrosis celular o tisular que seleccionan como diana específicamente catepsina C y/o CELA1 y/o CELA3A y/o enzimas estructuralmente relacionadas con las mismas |
| WO2017097113A1 (zh) * | 2015-12-10 | 2017-06-15 | 深圳市塔吉瑞生物医药有限公司 | 用于抑制蛋白酪氨酸激酶活性的氨基嘧啶类化合物 |
-
2019
- 2019-06-24 EP EP19826742.9A patent/EP3814324A4/en not_active Withdrawn
- 2019-06-24 WO PCT/CN2019/092488 patent/WO2020001392A1/en not_active Ceased
- 2019-06-24 JP JP2021500105A patent/JP2021530470A/ja active Pending
- 2019-06-24 CN CN201980055883.7A patent/CN112601742A/zh active Pending
-
2020
- 2020-12-30 US US17/137,458 patent/US20210114983A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023516073A5 (enExample) | ||
| JP2021514400A5 (enExample) | ||
| CN114555588A (zh) | 作为axl抑制剂的喹唑啉类化合物 | |
| JP2016518437A5 (enExample) | ||
| HUP0303637A2 (hu) | Nitrogéntartalmú spirotriciklusos-származékok, eljárás előállításukra, valamint ezeket tartalmazó foszfodiészteráz-7-inhibitorként alkalmazható gyógyszerkészítmények | |
| AU2014267235A1 (en) | Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B | |
| MX2011009822A (es) | Derivados de tienopirimidinadiona como moduladores del trpa1. | |
| JP2013516393A5 (enExample) | ||
| MX2011009821A (es) | Derivados de isotiazolo pirimidinadiona como moduladores del trpa1. | |
| JP2017524668A5 (enExample) | ||
| EA022420B1 (ru) | Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5) | |
| JP2010504346A5 (enExample) | ||
| JP2014526500A5 (enExample) | ||
| JP2015512435A5 (enExample) | ||
| ME01294B (me) | Nova jedinjenja i kompozicije i metode upotrebe | |
| JP2008516986A5 (enExample) | ||
| JP2018536678A5 (enExample) | ||
| JP2018511647A5 (enExample) | ||
| RU2010126105A (ru) | Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства | |
| JP2013532652A5 (enExample) | ||
| JP2014532626A5 (enExample) | ||
| EP2483242A1 (en) | New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers | |
| JP2013517279A5 (enExample) | ||
| MX2013008718A (es) | Inhibicion de il17 e ifn-gamma para tratamiento de inflamacion autoinmune. | |
| JP2021535213A5 (enExample) |